Matchstick-sized device implanted under the skin every 6-12 months. New data in over 4,000 people demonstrates it is safe for heart health. Could it launch by late 2017?

What does A1c miss and what can we do about it?

Tighter requirements for home meters. What does this mean for current and future blood glucose monitors?

Who is “closing the loop,” and how fast are they moving?

Coming in 2-3 years. How will it give patients and providers better advice?

Adds waterproof, color screen, and remote meter bolus. Will it speed FDA review of the 670G hybrid closed loop?

No fingersticks needed? Plus, a look at the “thinnest CGM ever” from Dexcom and Verily

Views on FDA regulation, pipeline updates, and first vs. next-generation systems.

Launches in the next 12-18 months. What we’re excited about…!

TCOYD’s CGM Medicare Appeals Assistance Program may be able to help!

Glucose, food, exercise, and even DIY closed loop on the phone

Details on monthly test strip subscription plan and our first impressions.

The artificial pancreas is here for those willing to build their own; what can manufacturers learn from OpenAPS?

A1c cannot capture the whole picture – hypoglycemia, time in range, and quality of life add so much more!

Abbott’s free Android app for caregivers is now available

How many people have type 1? What are the barriers to using new therapies? What outcomes matter beyond A1c?

Understanding the UnitedHealthcare/Medtronic partnership in the context of the Affordable Care Act.

Brings real-time insulin tracking, history, and a bolus calculator to injectors; launch in 2017

New OneTouch Reveal app works with Apple and Android phones. Plus, a future partnership to integrate WellDoc’s FDA-approved BlueStar software.

Six systems expected by 2019, plus an FAQ! Which system is right for me?